You are here: Industry Insights > Lung

News List

Plerixafor may protect against smoke-related COPD symptoms europeanpharmaceuticalreview
July 06, 2018
A drug used in stem cell therapy to treat certain cancers may also protect against cigarette smoke-induced lung injury…
New drugs could also be deployed against lung and pancreatic cancers worldpharmanews
June 05, 2018
A new anti-cancer drug may be effective against a wider range of cancers than previously thought. Using a mouse model and samples taken from cancer patients
Lung-on-a-chip simulates pulmonary fibrosis europeanpharmaceuticalreview
May 31, 2018
New biotech could reduce time and cost of developing medicine for deadly lung disease…
NTU launches nationwide research for lung health biospectrumasia
March 21, 2018
This will allow medical decisions, practices and interventions to be tailored to Asians and the individual rather than the disease.
Takeda’s lung cancer drug approved in the US pharmatimes
May 03, 2017
Takeda Pharmaceuticals has bagged approval for Alunbrig in the US as a treatment for a specific group of lung cancer patients.
BMS, Transgene to test new lung cancer combination therapy pharmatimes
April 26, 2017
Bristol-Myers Squibb and Transgene are to test a potential new therapy for advanced non-squamous non-small cell lung cancer (NSCLC)...
Roche's lung cancer c beats Pfizer rival in study pharmafile
April 11, 2017
Roche has announced that its drug Alecensa (alectinib) succeeded in meeting its primary endpoint in a Phase 3 trial ...
BMS’ Opdivo shown to improve five-year lung cancer survival pharmatimes
April 07, 2017
Bristol-Myers Squibb has unveiled “unprecedented” long-term survival data for its cancer immunotherapy Opdivo, showing ...
Pitt and Bayer to advance research for heart, lung and blood disease indications pharmaceutical-technology
January 13, 2017
The University of Pittsburgh (Pitt) and Bayer have collaborated to advance research for heart, lung and blood disease indications.

Previous page 1 2 3 4 5 6 7 8 9 Next page